Latest contributions
TAVI - Outcomes predictors
22 May 2025 – From EuroPCR 2025
Examine novel predictors of outcomes following TAVI. This session compares a new nutritional risk index against traditional scores for early post-TAVI mortality prediction and evaluates uric acid as a marker for aortic valve calcification and mortality risk in TAVI patients.
Best abstracts session #2
18 Dec 2024 – From GulfPCR-GIM 2024
This 'Best Abstracts' session features a diverse range of cutting-edge research in interventional cardiology. Explore insights into the Canadian experience with balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension, gain mechanistic understanding of iatrogenic coronary artery dissections through direct angioscopic visualization, and delve into the outcomes...
Featured cases - Tricuspid TEER
26 Nov 2024 – From PCR London Valves 2024
Delve into this session featuring selected clinical cases from PCR London Valves 2024, focusing on the use of transcatheter edge-to-edge repair (TEER) for the treatment of tricuspid regurgitation. Explore innovative techniques such as the use of the Pascal device in a patient with dextrocardia, the combination...
Featured Research - Tricuspid valve (Part 3)
25 Nov 2024 – From PCR London Valves 2024
Dive into the latest advancements in tricuspid valve interventions in this featured research session. Explore the systematic review of novel balloon-expandable valves across different cardiac locations, the impact of transcatheter tricuspid valve repair on patient health status, and the value of the pulmonary artery pulsatility index...
Featured research - Aortic valve (Part 1)
24 Nov 2024 – From PCR London Valves 2024
Dive into the latest research on aortic valve interventions in this two-part featured research session. Explore a wide range of topics, including the safety and efficacy of novel transcatheter aortic valve systems, hemodynamic outcomes, risk scoring, and peri-procedural considerations.
Featured research - Tricuspid valve (Part 2)
24 Nov 2024 – From PCR London Valves 2024
Delve into the latest research on tricuspid valve interventions in this second featured session from PCR London Valves 2024. Gain insights into the characteristics and outcomes of severe isolated tricuspid regurgitation across different treatment strategies, the issue of valve thrombosis after TTVR, the one-year robustness of...
New evidence on TAVI from PCR Companions
17 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 abstract submissions presenting the latest evidence on TAVI. Topics include device success in valve-in-valve TAVI, next-day discharge after TAVI, comparative network meta-analysis of PCI strategies in TAVI patients, factors associated with thrombosis treatment response, and outcomes of a novel balloon-expandable...
LANDMARK RCT - Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial
15 May 2024 – From EuroPCR 2024
This session provides an overview of the early outcomes of the LANDMARK trial, a randomized non-inferiority trial comparing TAVI devices. It examines baseline characteristics, the significance of intermediate sizes according to MSCT recommendations, real-world representative cases from the LANDMARK RCT, insights from quantitative aortography and echocardiography...
TAVI - Patient selection
20 Nov 2023 – From PCR London Valves 2023
Gain essential insights into TAVI patient selection through these selected abstract submissions from PCR London Valves 2023: explore the benefits of guideline-directed therapy for severe aortic stenosis, unravel the significance of subthreshold aortic valve calcium scores in patients with cardiac amyloidosis and aortic stenosis, delve into...
Top Innovations
20 Nov 2023 – From PCR London Valves 2023
Discover the future of cardiac care with these 3 top innovations! ARTERY, revolutionizing structural heart treatment, Vesalius Transfemoral DMR Repair, combining chordal and annular support in one-transfemoral device, and Approxima, a right ventricular reshaping device, offering a fresh perspective on tricuspid regurgitation.
TAVI - computer simulation and pre-procedural modelling
19 Nov 2023 – From PCR London Valves 2023
Valvular heart disease: novel transcatheter approaches
18 May 2023 – From EuroPCR 2023
Explore this thrilling session on transcatheter approaches for valvular heart disease, featuring the latest advancements, emerging techniques, and revolutionary research. Join your peer as they present novel strategies and devices aimed at improving valvular disease management.
Diagnosis of disease type and of disease severity
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult this session to learn how to better assess mitral regurgitation and how to better diagnose mitral stenosis through imaging.
Imaging before and after TAVI - How to treat
10 Mar 2023 – From PCR Imaging Valves Madrid 2023
Consult this session on imaging before and after TAVI to learn how to better select patients for TAVI, to understand how to treat paravalvular leak and to know how to deal with and prevent valve thrombosis.
Innovation fireworks
20 May 2022 – From EuroPCR 2022
Find out more about novel innovative techniques and devices including: Leaflex, a possible alternative to balloon valvuloplasty, Valvosoft, a non-invasive ultrasound therapy or even home blood potassium monitoring!
PCR Innovators Day - Machine learning and artificial intelligence
19 May 2022 – From EuroPCR 2022
Learn more about machine learning and artificial intelligence for automated assessment of CAD, risk assessment and early patient stratification, continuous monitoring of cardiac performance, and much more!
PCR Innovators Day - Innovations for valve treatment: new devices, new tools, new procedures
19 May 2022 – From EuroPCR 2022
Valvular heart disease is probably one of the most innovative areas in cardiovascular medicine at large: tremendous progress has been made both in terms of quality of life and mortality. Technology continues to evolve, as there are still many gaps to be filled, and it is...
Mitral paravalvular leak and other challenges
18 May 2022 – From EuroPCR 2022
In this EuroPCR 2022 session, view complex percutaneous mitral paravalvular leak closures, a difficult mitral commissurotomy, percutaneous indirect annuloplasty for functional mitral insufficiency, and much more!
Emerging indications for TAVI
17 May 2022 – From EuroPCR 2022
TAVI in severe calcified anatomy
17 May 2022 – From EuroPCR 2022
Consult this session to discover some complex TAVI cases in severe calcified anatomy, such as: high-risk aortic stenosis patient treated with orbital atherectomy, IVL and TAVI, antegrade-retrograde technique in uncrossable aortic valve, TAVI in severe calcified bicuspid aortic valve with LV apical clot, and much more!
Abstracts on TAVI
08 Oct 2021 – From AICT AsiaPCR 2021
Watch this session to discover a selection of abstracts on TAVI, and learn more about the operator preference and determinants of size when additional intermediate-size aortic THVs available, the comparative quantitative aortographic assessment of regurgitation in six self-expanding valves, as well as the chronic hemodynamic performance...
Quantitative angiographic assessment of regurgitation in the era of minimalistic TAVI and MitraClip
23 May 2019 – From EuroPCR 2019
Consult this session to learn about the quantitative angiographic technique to assess valve regurgitation, the potential value of this technique to guide the procedure, and the current limitations and pitfalls of this technology.
